Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
24/7 Wall St.2d agobearish
5 High-Yield Dividend Stocks That Could Hold Up When the Market FallsMT Newswires5d agobearish
Pfizer Fiscal Q3 Adjusted Earnings Flat, Revenue Falls; Raises 2026 Guidance24/7 Wall St.39d agobearish
Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay FlatInsider Monkey54d agobearish
AstraZeneca’s Oncology Engine Faces a Key Test After Camizestrant MissThe Wall Street Journal55d agobearish
AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial24/7 Wall St.60d agobearish
How a 74-Year-Old Collects $8,900 a Month Without Selling a Single ShareMT Newswires72d agobearish
BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares FallInvesting.com72d agobearish
Alnylam stock drops on rival heart trial: Why analysts see core business safeFastCompany87d agobearish
Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get moneyPharmaceutical Technology96d agobearish
Pfizer repels Covid-19 sales tumble to raise 2026 guidanceInvestor's Business Daily96d agobearish
Pfizer Hikes 2026 Sales Outlook By $500 Million On Second-Quarter BeatSimply Wall St.109d agobearish
Pfizer (PFE) Faces Expanded Vaccine Lawsuits On A Fair Value Narrative That Still Sees UpsideSimply Wall St.111d agobearish
Pfizer (PFE) Faces New International Patent Lawsuits Over Covid 19 Vaccine